This inventor holds 3 USPTO granted patents. Top assignee: Eisai Company, Limited. Active years: 1984-1990.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Saitama, JP (1984 - 1989)
- Honjou, JP (1990)
Company Filing History:
Years Active: 1984-1990
Title: The Innovative Contributions of Yoshio Kogure
Introduction
Yoshio Kogure is a notable inventor based in Saitama, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative solutions for eye care and lipid-soluble substances. With a total of 3 patents to his name, Kogure's work has the potential to impact the medical industry positively.
Latest Patents
Kogure's latest patents include a clear solution containing lysozyme hydrochloride and dipotassium. This aqueous solution is designed for use in eye drops and comprises various components that ensure its effectiveness and stability. Another significant patent is an aqueous solution containing a lipid-soluble pharmaceutical substance. This solution is notable for its stability and ease of preparation, making it a valuable addition to the pharmaceutical landscape.
Career Highlights
Yoshio Kogure is currently associated with Eisai Company, Limited, where he continues to innovate and contribute to the field of pharmaceuticals. His work focuses on creating solutions that are not only effective but also safe for consumers. Kogure's dedication to research and development has positioned him as a key figure in his field.
Collaborations
Throughout his career, Kogure has collaborated with esteemed colleagues such as Toru Takami and Noritoshi Koyama. These collaborations have fostered an environment of innovation and have led to the successful development of various pharmaceutical solutions.
Conclusion
Yoshio Kogure's contributions to the pharmaceutical industry through his innovative patents and collaborations highlight his importance as an inventor. His work continues to pave the way for advancements in medical solutions, particularly in eye care and lipid-soluble substances.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
